NCT01283958

Brief Summary

Identification of the pathophysiology associated with Eisenmenger's syndrome has led to the evaluation of targeted therapies. Iloprost, a prostacyclin analogue, is one such targeted therapy used in patients with Eisenmenger's syndrome. The purpose of our study is to assess the effects of inhaled iloprost on patients with Eisenmenger's syndrome.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
12

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2007

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2007

Completed
2.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2010

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

January 25, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

January 26, 2011

Completed
Last Updated

January 26, 2011

Status Verified

May 1, 2010

First QC Date

January 25, 2011

Last Update Submit

January 25, 2011

Conditions

Eisenmenger's Syndrome

Keywords

Iloprost, Eisenmenger's syndrome

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

12 patients with Eisenmenger's syndrome diagnosed by right side cardiac catheterization

You may qualify if:

  • patients with Eisenmenger's syndrome diagnosed by right side cardiac catheterization

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Eisenmenger Complex

Condition Hierarchy (Ancestors)

Heart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesHeart DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 25, 2011

First Posted

January 26, 2011

Study Start

September 1, 2007

Study Completion

May 1, 2010

Last Updated

January 26, 2011

Record last verified: 2010-05